With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Jonathan Edelman, senior vice president of CSL’s vaccines innovation unit, said the approval “marks a significant milestone” ...

Significant research news last week included a setback for Pliant Therapeutics, when it paused a Phase IIb trial of its bexotegrast in idiopathic pulmonary fibrosis (IPP). Also, US biotech AnaptysBio ...

The European Commission has granted marketing authorization for Kostaive (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...

TruDiagnostic, a leader in epigenetic testing and research, has announced the launch of the TruDiscovery Grant which offers $400,000 in funding for researchers and organizations pioneering ...

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...

Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...

CSL, the leading European provider of critical IoT connectivity, is pleased to announce its strategic acquisition of EdgeConnect, a multi-award-winning specialist internet connectivity solutions ...

Arcturus Therapeutics, founded in 2013, is known for developing KOSTAIVE®, the first self-amplifying mRNA COVID vaccine to receive approval. The company's collaborations and joint ventures extend ...